.00 Highlights from our Annual Report 2016-17
.03 Science transforms our lives and secures our future.
.09 An ambition we are realising every day.
.14 We worked with 1700+ industry customers including
.16 400 major Australian companies
.19 49 US Fortune 500
.23 1000 SMEs
.25 Increasingly satisfied customers
.26 Awarded Boeing’s Supplier of the Year Technology Award
0.32 Equity portfolio grown by 20 million
0.37 Increase in active licences
0.41 $3.2 billion Estimated value we contribute annually to the nation across 28 case studies
0.47 ON program Graduated135 teams and counting
0.51 130,000 school students participated in science education programs
0.57 Research cited 51% more than global average
1.09 Collaborated on 84% of our publications many international
1.09 New initiatives to support our people. Balance, our flexible work arrangements
1.12 Reconciliation Action Plan working with Aboriginal and Torres Strait Islander peoples to achieve positive outcomes
1.16 SAGE our commitment to improve gender equity in STEMM
1.21 Taking our science to the world
1.25 Novacq prawn feed additive licensed world-wide
1.29 Survey of the ocean depths off Australia’s eastern coastline
1.32 5000 specimens collected
1.35 1/3 of the invertebrates considered new species
1.38 Confirmed the first national outbreak of white spot disease in prawns
1.42 We partnered with industry to bring our PhotonAssay gold analysis technology to market
1.47 We partnered with Clinical Genomics to launch a new blood test for bowel cancer recurrence in the US
1.51 Cancer Therapeutics CRC partnered with us to bring a new targeted cancer treatment to clinical trials
2.0 Ideas for the future
2.02 6 future science platforms
2.03 3 industry roadmaps and counting
2.07 We opened: US office Silicon Valley,
2.10 Australian Square Kilometre Array Pathfinder Murchison, WA
2.13 Centre for Southern Hemisphere Ocean Research Hobart
2.18 I’m so proud to reflect on the past year and see our significant strides forward to solve our nation’s biggest challenges as we deliver on Strategy 2020. Thank you to each and every one of you who have brought our strategy to life. Larry Marshall, Chief ExecutiveHide transcript
in partnership with CSIRO, the Cancer Therapeutics CRC (CTx) developed a NEW CANCER DRUG that is being taken to clinical trials.
of marine life and the geophysical features of the abyss from Tasmania to Queensland was undertaken on the RV Investigator.
informed the Council of Australian Governments Energy Council’s work on the future of our electricity system.
opened and observations commenced in October 2016 for a giant census of galaxies called WALLABY.
signed with Ridley Corporation to further the technology research on our prawn feed additive, Novacq™.
uptake across major hospitals and state health systems.
detects atoms of gold in real time drastically improving mining efficiency and effectiveness.
simulates and predicts the physical state of the Great Barrier Reef and is informing public policy.
developed in collaboration with the Indonesian Government that identifies and ranks vessels at sea associated with illegal, unregulated fishing.